HPV testing preferred over Pap for cervical cancer screening starting at age 30, task force’s draft recommendation says – CNN

A new draft recommendation from the US Preventive Services Task Force suggests that testing for high-risk human papillomaviruses every five years, even with a self-collected sample, is the preferred screening strategy for cervical cancer starting at age 30.

Traditionally, women have been screened for cervical cancer using Pap tests or Pap smears, which involve collecting and examining cells from the cervix for signs of cancer. However, the draft recommendation emphasizes testing for high-risk HPV as the primary screening approach for women aged 30 to 65, as most cervical cancers are caused by this virus. The HPV test entails collecting a vaginal sample and checking for infection with high-risk HPV strains that can lead to cervical cancer.

Dr. Esa Davis, a member of the task force, highlighted that HPV screening is the best balance between benefits and harms in detecting cervical cancer, especially for women in the 30-65 age group. The draft recommendation also introduces the option for women to self-collect their vaginal samples for HPV testing, providing a more accessible screening method for those who may not otherwise seek screening.

When HPV testing is unavailable, the recommendation suggests performing a Pap test or co-testing with both HPV testing and cervical cytology as alternative screening options. The update in the draft recommendation reflects the effectiveness of HPV testing as a screening tool for cervical cancer in women aged 30 to 65, while continuing to recommend cervical cytology every three years for women in their 20s.

The draft recommendation is open for public comment until January 13 and includes the option for self-collected vaginal samples for HPV testing. The American Cancer Society also supports HPV testing as part of cervical cancer screening, emphasizing the importance of regular screening to prevent and treat this highly preventable cancer.

HPV, a group of viruses primarily spread through sexual contact, includes high-risk strains associated with certain cancers. Detecting high-risk HPV early is crucial for monitoring and preventing potential health issues like cancer. The new draft recommendation aims to improve access to screening, especially with the FDA’s recent approval of self-collection options for HPV testing.

Overall, regular screening for cervical cancer is essential for women aged 21 to 65, as early detection significantly impacts treatment outcomes. The introduction of self-collection HPV tests provides a more comfortable and accessible screening option for women, potentially increasing screening rates and reducing barriers to preventive care.